Characteristics associated with the risk of psychosis among immigrants and their descendants in France.


Journal

Brain and behavior
ISSN: 2162-3279
Titre abrégé: Brain Behav
Pays: United States
ID NLM: 101570837

Informations de publication

Date de publication:
05 2021
Historique:
revised: 11 01 2021
received: 11 06 2020
accepted: 15 02 2021
pubmed: 10 4 2021
medline: 1 7 2021
entrez: 9 4 2021
Statut: ppublish

Résumé

To explore the sociodemographic characteristics that might explain the increased incidence of psychosis among immigrants and their descendants in France. Data were collected for all subjects with first contact for psychosis aged between 18 and 64 years, in two catchment areas in the Paris region. Incidence rates (IR) and incidence rate ratios (IRR) were adjusted for gender and age. During 805,396 persons-year at risk, we identified 321 cases of first-episode psychosis, of which 129 were immigrants and 78 descendants of immigrants. We found that the geographic origin was associated with the risk of psychosis although generation has little impact. Sub-Saharan African immigrants and their descendants showed the highest risk (IRR = 3.1 and IRR = 2.9, respectively). We observed that living in deprived areas increased the incidence of psychosis (IRR = 1.3, 95CI%: 1.0-1.6), particularly among immigrants (IRR = 1.6; 95% CI: 1.1-2.5). Finally, our study showed that subjects having unstable housing (a proxy for "hard to count population") could inflate the incidence rates among immigrants. The current study shows that the increased risk of psychosis in groups with an immigration background in France is associated with their origin and highlights the importance of socioeconomic factors in modulating this risk.

Identifiants

pubmed: 33835727
doi: 10.1002/brb3.2096
pmc: PMC8119809
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e02096

Informations de copyright

© 2021 The Authors. Brain and Behavior published by Wiley Periodicals LLC.

Références

Clin Psychol Rev. 2008 Feb;28(2):211-27
pubmed: 17587473
Schizophr Bull. 2014 Jan;40(1):169-80
pubmed: 23236081
Int J Epidemiol. 2007 Aug;36(4):761-8
pubmed: 17517810
J Health Soc Behav. 2003 Sep;44(3):302-17
pubmed: 14582310
PLoS Med. 2008 Dec 2;5(12):e225
pubmed: 19053169
JAMA Psychiatry. 2018 Jan 1;75(1):36-46
pubmed: 29214289
Psychol Med. 2015 Mar;45(4):727-34
pubmed: 25084213
Soc Psychiatry Psychiatr Epidemiol. 2015 Jul;50(7):1057-64
pubmed: 25208909
Psychol Med. 2011 May;41(5):897-910
pubmed: 20663257
Schizophr Bull. 2006 Oct;32(4):592-8
pubmed: 16849399
Psychol Med. 2016 Jul;46(10):2015-23
pubmed: 27216635
World Psychiatry. 2019 Oct;18(3):247-258
pubmed: 31496097
Dialogues Clin Neurosci. 2010;12(3):305-15
pubmed: 20954427
Psychol Med Monogr Suppl. 1992;20:1-97
pubmed: 1565705
Schizophr Res. 2013 Oct;150(1):223-8
pubmed: 23932446
BMJ. 2016 Mar 15;352:i1030
pubmed: 26979256
Schizophr Bull. 2010 Nov;36(6):1073-8
pubmed: 20833696
Soc Psychiatry Psychiatr Epidemiol. 2015 Nov;50(11):1723-9
pubmed: 26290165
Schizophr Bull. 2014 Jul;40(4):729-36
pubmed: 24860087
Can J Psychiatry. 2004 May;49(5):335-8
pubmed: 15198471
Br J Psychiatry. 1999 Sep;175:283-5
pubmed: 10645332
Soc Psychiatry Psychiatr Epidemiol. 2008 Dec;43(12):937-9
pubmed: 18587677
Am J Psychiatry. 2002 Apr;159(4):669-71
pubmed: 11925311
Int J Soc Psychiatry. 2002 Jun;48(2):126-38
pubmed: 12182508
Schizophr Res. 2006 Sep;86(1-3):189-93
pubmed: 16839747
BMC Public Health. 2009 Jun 30;9:214
pubmed: 19566954
Soc Psychiatry Psychiatr Epidemiol. 2014 Jul;49(7):1103-9
pubmed: 24270936
Brain Behav. 2021 May;11(5):e02096
pubmed: 33835727
Schizophr Res. 2013 Jun;147(1):193-195
pubmed: 23570896
Schizophr Res. 2014 Jun;156(1):115-21
pubmed: 24731617
Biol Psychiatry. 2017 Jan 1;81(1):9-20
pubmed: 27720198
Eur J Public Health. 2016 Feb;26(1):71-6
pubmed: 26511600
CMAJ. 2015 Jun 16;187(9):E279-E286
pubmed: 25964387
Schizophr Res. 2016 May;173(1-2):90-3
pubmed: 26969451
Schizophr Bull. 2013 Nov;39(6):1180-6
pubmed: 24062592
Soc Psychiatry Psychiatr Epidemiol. 2015 Jul;50(7):1039-55
pubmed: 25660551
Psychol Med. 2020 Mar 03;:1-13
pubmed: 32122439
Soc Psychiatry Psychiatr Epidemiol. 2013 May;48(5):685-92
pubmed: 22893107
Prog Neuropsychopharmacol Biol Psychiatry. 2013 Apr 5;42:5-19
pubmed: 22800757

Auteurs

Andrea Tortelli (A)

INSERM U955 Translational Neuropsychiatry, Créteil, France.
Pôle GHU Psychiatrie Précarité, Groupe Hospitalier Universitaire Paris Psychiatrie & Neurosciences, Paris, France.
Institut Convergences Migrations, Aubervilliers, France.

Patrick Simon (P)

Institut Convergences Migrations, Aubervilliers, France.
Institut National d'Etudes Démographiques, Aubervilliers, France.

Sophie Lehouelleur (S)

Institut National d'Etudes Démographiques, Aubervilliers, France.

Norbert Skurnik (N)

Groupe Hospitalier Universitaire Paris Psychiatrie & Neurosciences, Paris, France.

Jean Romain Richard (JR)

INSERM U955 Translational Neuropsychiatry, Créteil, France.

Grégoire Baudin (G)

Laboratoire de Psychopathologie et Processus de Santé, Université de Paris, EA 4057, Boulogne-Billancourt, France.

Aziz Ferchiou (A)

INSERM U955 Translational Neuropsychiatry, Créteil, France.
AP-HP, DMU IMPACT, Hôpitaux Universitaires Henri-Mondor, Créteil, France.

Marion Leboyer (M)

INSERM U955 Translational Neuropsychiatry, Créteil, France.
AP-HP, DMU IMPACT, Hôpitaux Universitaires Henri-Mondor, Créteil, France.
Fondation FondaMental, Créteil, France.
UPEC, University Paris-Est, Créteil, France.

Franck Schürhoff (F)

INSERM U955 Translational Neuropsychiatry, Créteil, France.
AP-HP, DMU IMPACT, Hôpitaux Universitaires Henri-Mondor, Créteil, France.
Fondation FondaMental, Créteil, France.
UPEC, University Paris-Est, Créteil, France.

Andrei Szöke (A)

INSERM U955 Translational Neuropsychiatry, Créteil, France.
AP-HP, DMU IMPACT, Hôpitaux Universitaires Henri-Mondor, Créteil, France.
Fondation FondaMental, Créteil, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH